Insider Transactions in Q3 2021 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,677
+0.04%
|
$454,894
$22.85 P/Share
|
|
Sep 27
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,000
-3.93%
|
$168,000
$24.32 P/Share
|
|
Sep 27
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+3.78%
|
$49,000
$7.78 P/Share
|
|
Sep 27
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,000
+0.05%
|
$1,152,000
$24.53 P/Share
|
|
Sep 24
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,000
+0.07%
|
$828,000
$23.4 P/Share
|
|
Sep 23
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
54,778
+0.05%
|
$1,259,894
$23.25 P/Share
|
|
Sep 22
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
84,018
+0.17%
|
$1,764,378
$21.96 P/Share
|
|
Sep 21
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
43,000
+0.09%
|
$946,000
$22.48 P/Share
|
|
Sep 20
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
38,273
+0.08%
|
$842,006
$22.1 P/Share
|
|
Sep 17
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,913
+0.08%
|
$834,086
$22.79 P/Share
|
|
Sep 16
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,000
+0.1%
|
$1,050,000
$21.75 P/Share
|
|
Sep 15
2021
|
Uneek Mehra Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
103,069
+50.0%
|
-
|
|
Sep 15
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
89,864
+0.18%
|
$1,887,144
$21.98 P/Share
|
|
Sep 14
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
71,300
+0.07%
|
$1,568,600
$22.4 P/Share
|
|
Sep 13
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
83,178
+0.08%
|
$1,913,094
$23.5 P/Share
|
|
Sep 10
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.06%
|
$750,000
$25.11 P/Share
|
|
Sep 09
2021
|
Terrie Curran Director |
SELL
Open market or private sale
|
Direct |
4,850
-100.0%
|
$121,250
$25.58 P/Share
|
|
Sep 09
2021
|
Terrie Curran Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,850
+50.0%
|
$33,950
$7.65 P/Share
|
|
Sep 09
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,000
+0.07%
|
$925,000
$25.52 P/Share
|
|
Sep 08
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,902
+0.04%
|
$547,550
$25.74 P/Share
|
|
Sep 07
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
33,200
+0.03%
|
$863,200
$26.6 P/Share
|
|
Sep 03
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
31,200
+0.03%
|
$842,400
$27.02 P/Share
|
|
Sep 02
2021
|
Terrie Curran Director |
SELL
Open market or private sale
|
Direct |
37,135
-100.0%
|
$928,375
$25.03 P/Share
|
|
Sep 02
2021
|
Terrie Curran Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,135
+50.0%
|
$259,945
$7.65 P/Share
|
|
Sep 02
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
63,102
+0.04%
|
$1,640,652
$26.22 P/Share
|
|
Sep 01
2021
|
Terrie Curran Director |
SELL
Open market or private sale
|
Direct |
11,373
-100.0%
|
$284,325
$25.0 P/Share
|
|
Sep 01
2021
|
Terrie Curran Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,373
+50.0%
|
$79,611
$7.65 P/Share
|
|
Sep 01
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.08%
|
$960,000
$24.83 P/Share
|
|
Aug 31
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,000
+0.08%
|
$936,000
$24.28 P/Share
|
|
Aug 30
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
70,000
+0.14%
|
$1,610,000
$23.92 P/Share
|
|
Aug 30
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,000
-10.92%
|
$504,000
$24.05 P/Share
|
|
Aug 30
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+9.84%
|
$147,000
$7.78 P/Share
|
|
Aug 27
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,978
-1.14%
|
$43,516
$22.69 P/Share
|
|
Aug 27
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,038
+0.08%
|
$851,874
$23.17 P/Share
|
|
Aug 26
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,000
+0.08%
|
$880,000
$22.67 P/Share
|
|
Aug 25
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,709
+0.06%
|
$631,598
$22.44 P/Share
|
|
Aug 24
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
34,299
+0.07%
|
$754,578
$22.37 P/Share
|
|
Aug 23
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
55,447
+0.06%
|
$1,219,834
$22.29 P/Share
|
|
Aug 20
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,478
+0.1%
|
$929,560
$20.86 P/Share
|
|
Aug 19
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,792
+0.1%
|
$982,632
$21.51 P/Share
|
|
Aug 18
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,116
+0.04%
|
$359,436
$21.45 P/Share
|
|
Aug 17
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
23,549
+0.05%
|
$470,980
$20.89 P/Share
|
|
Aug 16
2021
|
Sumitomo Chemical Co., Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,167
+0.05%
|
$1,011,507
$21.62 P/Share
|
|
Jul 09
2021
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
6,954
-3.59%
|
$146,034
$21.52 P/Share
|
|
Jul 07
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
3,232
-1.5%
|
$67,872
$21.75 P/Share
|
|
Jul 07
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,777
-1.58%
|
$58,317
$21.75 P/Share
|